Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Compensation for Blindness With the Intelligent Retinal Implant System (IRIS V2) in Patients With Retinal Dystrophy

NCT02670980 is registered in ClinicalTrials.gov with Science Corporation as lead sponsor.

NCT NCT02670980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02670980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Compensation for Blindness With the Intelligent Retinal Implant System (IRIS V2) in Patients With Retinal Dystrophy
Lead sponsor
Science Corporation
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2016
Completion date
May 31, 2019
Enrollment
10 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

choroideremia, cone rod dystrophy, retinitis pigmentosa